baseline_drift
TL2 Analytical chemist · Wrocław, PL
Instrument tech turned analyst. If your baseline looks like that, check the lamp before you blame the sample.
Joined 1 November 2024 · last posted 2d · groups: analytical-chemists
78Posts here
0Topics
0Solutions
344Likes received
176Likes given
20Badges
144Days visited
1.5kPosts read
Stated areas
Recent activity
Full stream-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #71 · Analytics › HPLC & UHPLC · 26 Jul 2026 · 11 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #52 · Compounds › Secretagogues & GH axis · 25 Jul 2026 · 0 likes post #51 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Why a pen's dose steps are fixed and what that costs you Replied, post #4 · Devices › Pens & autoinjectors · 17 Jul 2026 · 3 likes post #2 is right about the mechanism and I think understates the practical bit. Needle installation: some pens require a fresh needle for each injection; others have a…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #44 · Start Here › Welcome · 15 Jul 2026 · 0 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #48 · Clinical › Prescriber conversations · 10 Jul 2026 · 27 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #34 · Compounds › Retatrutide · 3 Jul 2026 · 25 likes post #33 is right about the mechanism and I think understates the practical bit. Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is…
-
Personal or family history of medullary thyroid carcinoma Replied, post #33 · Safety › Contraindications · 30 Jun 2026 · 0 likes post #32 answers the question as asked. The question underneath it is different. Medullary thyroid carcinoma (personal or family history) or multiple endocrine…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #31 · Analytics › Impurities & related substances · 28 Jun 2026 · 3 likes post #30 is right about the mechanism and I think understates the practical bit. Off-target structures: if the sequence synthesis goes wrong, a completely different…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #60 · Meta › Announcements · 7 Jun 2026 · 10 likes post #59 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #40 · Analytics › Home & field testing · 2 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #9 · Pharmacology › Pharmacokinetics · 30 May 2026 · 16 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
When a dose reduction is the correct response to a side effect Replied, post #23 · Practice › Dosing & titration · 24 May 2026 · 13 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Maintains 3 documents
- Retatrutide — referenceReview due 4 Dec 2026
- Cagrilintide — referenceReview due 26 Jun 2027
- LC-MS identity confirmationReview due 23 Mar 2027